SCHEMBL2913436

SCHEMBL2913436

Nc1nc(NCCCn2cc(-c3ccc(Cl)cc3Cl)cc2C(=O)NCCO)ccc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.48
GSK3A P49840 3/20 0.48
CDK1 P06493 2/20 0.46
CCNB2 O95067 1/20 0.45
CCNB1 P14635 1/20 0.45
CCNB3 Q8WWL7 1/20 0.45
ALPL P05186 3/20 0.37
ALPG P10696 1/20 0.37
CNR1 P21554 4/20 0.35
LMNA P02545 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.34
GCGR P47871 2/20 0.33
CYP2C19 P33261 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2911878 0.92 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2903944 0.90 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912205 0.90 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907104 0.90 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904701 0.90 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2937412 0.89 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904013 0.89 GSK3B (0.52) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2905623 0.89 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911669 0.88 LMNA (0.53) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911942 0.88 CYP2C19 (0.50) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed